Epsilon Healthcare Limited (ASX:EPN)
Australia · Delayed Price · Currency is AUD 0.0260
0.00 (0.00%)
Sep 30, 2026, 12:24 PM AEST
Epsilon Healthcare Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13.58 | 9.39 | 5.6 | 6.65 | 4.65 | 5.5 | |
Revenue Growth | 121.40% | 67.74% | -15.81% | 42.99% | -15.39% | -20.93% |
Cost of Revenue | 5.64 | 3.75 | 1.43 | 1.84 | 3.42 | 3.57 |
Gross Profit | 7.94 | 5.65 | 4.17 | 4.81 | 1.24 | 1.92 |
Selling, General & Admin | 7.43 | 7.46 | 7.6 | 5.57 | 6.11 | 8.62 |
Research & Development | - | - | - | 0.05 | - | 0.17 |
Operating Expenses | 9.16 | 8.02 | 9.11 | 7.23 | 7.62 | 11.09 |
Operating Income | -1.22 | -2.38 | -4.94 | -2.42 | -6.39 | -9.17 |
Interest Expense | -0.94 | -1.1 | -1.15 | -0.52 | -0.4 | -0.87 |
Currency Exchange Gain (Loss) | -0.03 | -0.02 | -0.01 | -0.01 | -0 | -0.03 |
Other Non Operating Income (Expenses) | 1.47 | 0.48 | 0.47 | 0 | 1.34 | 2.48 |
EBT Excluding Unusual Items | -0.73 | -3.02 | -5.63 | -2.94 | -5.45 | -7.59 |
Impairment of Goodwill | - | - | - | - | - | -0.97 |
Gain (Loss) on Sale of Assets | - | - | - | -0.37 | -0.01 | - |
Asset Writedown | 0.77 | 0.77 | - | - | -6.91 | -1.54 |
Other Unusual Items | - | - | - | - | -1.77 | - |
Pretax Income | 0.05 | -2.25 | -5.63 | -3.31 | -14.14 | -10.11 |
Income Tax Expense | -0.02 | -0.97 | -0.13 | -2.22 | -0.54 | -0.86 |
Net Income | 0.06 | -1.28 | -5.49 | -1.09 | -13.61 | -9.24 |
Net Income to Common | 0.06 | -1.28 | -5.49 | -1.09 | -13.61 | -9.24 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 398 | 379 | 345 | 300 | 252 | 193 |
Shares Outstanding (Diluted) | 398 | 379 | 345 | 300 | 252 | 193 |
Shares Change | 8.12% | 9.77% | 14.98% | 19.01% | 30.79% | 21.43% |
EPS (Basic) | 0.00 | -0.00 | -0.02 | -0.00 | -0.05 | -0.05 |
EPS (Diluted) | 0.00 | -0.00 | -0.02 | -0.00 | -0.05 | -0.05 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.35 | -3.3 | -3.5 | -0.8 | -1.31 | -6.13 |
Free Cash Flow Per Share | 0.00 | -0.01 | -0.01 | -0.00 | -0.01 | -0.03 |
Gross Margin | 58.47% | 60.10% | 74.52% | 72.34% | 26.55% | 34.98% |
Operating Margin | -8.96% | -25.31% | -88.15% | -36.32% | -137.36% | -166.75% |
Profit Margin | 0.47% | -13.61% | -98.10% | -16.40% | -292.50% | -168.11% |
Free Cash Flow Margin | 2.56% | -35.09% | -62.56% | -12.08% | -28.15% | -111.56% |
EBITDA | -0.82 | -2.37 | -3.67 | -1.1 | -4.99 | -8.24 |
EBITDA Margin | -6.03% | -25.28% | -65.56% | -16.52% | -107.36% | -149.86% |
D&A For EBITDA | 0.4 | 0 | 1.27 | 1.32 | 1.4 | 0.93 |
EBIT | -1.22 | -2.38 | -4.94 | -2.42 | -6.39 | -9.17 |
EBIT Margin | -8.96% | -25.31% | -88.15% | -36.32% | -137.36% | -166.75% |
Advertising Expenses | - | 0.04 | 0 | 0.02 | 0.04 | 0.13 |